Biotech company in Princeton plans clinical tests of birth-control patch thanks to state-administered incentive program
If Princeton-based biotechnology firm Agile Therapeutics can eventually get federal approval to bring its promising new female contraceptive patch to market, credit will go to more than just the company’s employees and investors
{iframe}http://www.njspotlight.com/stories/16/02/23/swapping-tax-credits-for-needed-capital-helps-small-firms-pursue-big-goals/#{/iframe}